Hameed Afshan B, Tarsa Maryam, Graves Cornelia R, Grodzinsky Anna, Thiel De Bocanegra Heike, Wolfe Diana S
Maternal-Fetal Medicine, Obstetrics & Gynecology, Cardiology, University of California, Irvine, California, USA.
Division of Maternal-Fetal Medicine, University of California, San Diego, California, USA.
JACC Adv. 2024 Jun 23;3(8):101055. doi: 10.1016/j.jacadv.2024.101055. eCollection 2024 Aug.
The United States has the highest maternal mortality rate among developed countries, with cardiovascular disease (CVD) being one of the leading causes of maternal deaths. Diagnosing CVD during pregnancy may be challenging as symptoms of normal pregnancy overlap with those of CVD. Delays in recognition and response to the diagnosis of CVD is a missed opportunity for timely intervention to improve maternal outcomes. Implementing universal CVD risk assessment for all pregnant and postpartum patients across clinical care settings presents a pivotal opportunity to address this issue. Integrating a validated risk assessment tool into routine obstetric care, clinicians, including obstetricians, primary care, and emergency healthcare providers, can enhance awareness of cardiovascular risk and facilitate early CVD diagnosis. Consensus among stakeholders underscores the importance of screening and education on cardiovascular health strategies for pregnant and postpartum patients to reduce CVD-related maternal mortality. This comprehensive approach offers a pathway to identify at-risk individuals and intervene promptly, potentially saving lives and advancing maternal healthcare equity.
美国在发达国家中孕产妇死亡率最高，心血管疾病（CVD）是孕产妇死亡的主要原因之一。孕期诊断CVD可能具有挑战性，因为正常妊娠的症状与CVD的症状重叠。对CVD诊断的识别和反应延迟是及时干预以改善孕产妇结局的一个错失的机会。在所有临床护理环境中对所有孕妇和产后患者实施普遍的CVD风险评估，为解决这一问题提供了一个关键机会。将经过验证的风险评估工具纳入常规产科护理中，包括产科医生、初级保健医生和急诊医疗服务提供者在内的临床医生，可以提高对心血管风险的认识，并促进CVD的早期诊断。利益相关者之间的共识强调了对孕妇和产后患者进行心血管健康策略筛查和教育的重要性，以降低与CVD相关的孕产妇死亡率。这种综合方法提供了一条识别高危个体并及时进行干预的途径，有可能挽救生命并促进孕产妇医疗保健公平。
